ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2024

Evaluating the Overall Safety of Glucokinase Activators in Patients with Type 2 Diabetes Mellitus.

Ting-Ting Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.